Tag: ribonucleic acid sequencing market share

Uncover key drivers, emerging technologies, and competitive movements shaping the ribonucleic acid (rna) sequencing market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Ribonucleic Acid (RNA) Sequencing Market show for the 2026–2030 period?

The ribonucleic acid (rna) sequencing market has witnessed substantial expansion in recent years. Its value is projected to rise from $3.96 billion in 2025 to $4.84 billion in 2026, achieving a compound annual growth rate (CAGR) of 22.3%. This historical growth can be attributed to several factors, including the expansion of genomics research initiatives, decreasing sequencing expenses, increased funding for academic research, wider adoption of next-generation sequencing, and a heightened demand for gene expression analysis.

The ribonucleic acid (RNA) sequencing market is anticipated to experience significant expansion over the coming years. This market is projected to reach $9.63 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 18.8%. Several factors are driving this growth during the forecast period, including the wider acceptance of precision medicine strategies, increased funding for transcriptomics research, the broadening scope of clinical diagnostic sequencing, the expanding incorporation of AI-powered data analysis, and a heightened emphasis on personalized therapeutic solutions. Key trends anticipated in the forecast period encompass the increasing embrace of single-cell RNA sequencing, a surge in the deployment of high-throughput sequencing platforms, the deeper integration of sophisticated bioinformatics tools, the widening application of clinical and translational research, and a greater commitment to ensuring data accuracy and reproducibility.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15665&type=smp

What Drivers Are Shaping The Development Of The Ribonucleic Acid (RNA) Sequencing Market?

A heightened emphasis on precision medicine is anticipated to fuel the expansion of the ribonucleic acid (RNA) sequencing market in the coming years. Also known as personalized medicine, this advanced method for medical care and disease prevention takes into account each individual’s unique genetic makeup, environmental factors, and lifestyle choices. Personalized medicine offers the prospect of more effective treatments, drives advancements in genomics, helps navigate increasing disease complexity, and receives regulatory support. RNA sequencing technologies are employed to identify the sequence and measure the expression levels of RNA molecules present in a biological sample. This allows for a thorough analysis of transcriptomes, providing insights into various aspects such as gene expression patterns, alternative splicing occurrences, and RNA modifications. As an illustration, data from February 2024, sourced from the US-based non-profit organization, the Personalized Medicine Coalition, revealed that the FDA sanctioned 16 novel personalized therapies for individuals suffering from rare diseases in 2023, an increase from six approvals in 2022. Consequently, the heightened focus on precision medicine is a significant impetus for the ribonucleic acid (RNA) sequencing market.

Which Segments Are Contributing To The Growth Of The Ribonucleic Acid (RNA) Sequencing Market?

The ribonucleic acid (rna) sequencing market covered in this report is segmented –

1) By Product Type: Instruments, Reagents And Kits, Software

2) By Technology: Single Molecule Based Sequencing, Sequence By Synthesis Technology, Nanopore Sequencing Technology, Ion Torrent Semiconductor Sequencing

3) By Applications: Diagnostics, Drug Discovery, Translational Medicine, Other Applications

4) By End User: Research And Academia, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Instruments: Next-Generation Sequencers, Microarray Instruments, Single-Cell Rna Sequencing Instruments

2) By Reagents And Kits: Rna Extraction Kits, Rna Sequencing Kits, Library Preparation Kits

3) By Software: Data Analysis Software, Data Management Software, Bioinformatics Software

Which Market Trends Are Opening Growth Opportunities In The Ribonucleic Acid (RNA) Sequencing Market?

Key companies within the ribonucleic acid (RNA) sequencing market are concentrating on RNA next-generation sequencing assays to enhance patient care through data-driven insights and precision medicine. An RNA next-generation sequencing assay functions as an advanced exome sequencing platform, leveraging sophisticated genomic sequencing technologies to analyze a patient’s complete exome. For example, in June 2023, Tempus, a US-based precision medicine technology company, launched its new standalone RNA next-generation sequencing assay, Tempus xR. This innovative assay, developed for solid tumors, delivers a comprehensive analysis of the entire transcriptome, emphasizing clinically significant fusions in over 100 targeted genes and altered splicing for MET Exon 14 and EGFRvIII. This offering is designed to serve physicians with a specific focus on RNA fusions or altered splicing, alongside providers, researchers, and biopharma companies seeking in-depth RNA sequencing analysis of their existing samples.

Who Are The Major Companies Operating In The Ribonucleic Acid (RNA) Sequencing Market?

Major companies operating in the ribonucleic acid (rna) sequencing market are F Hoffmann La Roche Ltd, Thermo Fisher Scientific Inc, Danaher Corporation, Merck KGaA, Becton Dickinson And Company, Eurofins Scientific SE, Agilent Technologies Inc, Illumina Inc, PerkinElmer Inc, Beckman Coulter Inc, Bio Rad Laboratories Inc, QIAGEN NV, Tecan Genomics Inc, BGI Genomics Co Ltd, Takara Bio Inc, Abcam Limited, Oxford Nanopore Technologies plc, Pacific Biosciences Of California Inc, Macrogen Inc, Standard BioTools Inc, CD Genomics, Genewiz Inc, Novogene Co Ltd, GENEWIZ Germany GmbH, Azenta Life Sciences

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Ribonucleic Acid (RNA) Sequencing Market?

North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (rna) sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Ribonucleic Acid (RNA) Sequencing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15665&type=smp

Browse Through More Reports Similar to the Global Ribonucleic Acid (RNA) Sequencing Market 2026, By The Business Research Company

Protein Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-sequencing-global-market-report

Dna Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

Rna Sequencing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Big Is The Ribonucleic Acid (RNA) Sequencing Market Today And What Is Its Future Size?

The market for ribonucleic acid (rna) sequencing has seen an incredible expansion in past years. The forecast predicts a growth from $3.25 billion in 2024 to $3.96 billion in 2025, implying a compound annual growth rate (CAGR) of 21.8%. The significant growth during the previous years can be connected to increased drug development activities, higher incidence of genetic disorders and target diseases, an upsurge in the utilization of small-sized portable instruments, growing application of biomarker profiling, increasing demand for customized medicine, as well as a rise in the number of cancer cases.

Anticipated to witness a substantial surge over the coming years, the size of the ribonucleic acid (RNA) sequencing market is projected to clock in at $8.34 billion by 2029, with a compound annual growth rate (CAGR) of 20.5%. Factors propelling this growth within the projected timeframe include the escalating demand for quick and precise disease diagnosis, the increased implementation of real-time polymerase chain reaction, and the rising requirement for quick, on-site diagnostic tests, along with increases in disease outbreaks and the demand for companion diagnostics. Among the key trends that will define this forecast period are disease tracking and detection, drug discovery, verifying targets, identifying biomarkers, progress in DNA sequencing technology, advancements in diagnostic tests, the evolving next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and the development of cutting-edge molecular diagnostic solutions.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15665&type=smp

Which Key Factors Are Fueling Growth In The Ribonucleic Acid (RNA) Sequencing Market?

The escalating emphasis on precision medicine is likely to fuel the expansion of the ribonucleic acid (RNA) sequencing market in the future. This progressive method of medical prevention and treatment takes into account the unique genetic, environmental, and lifestyle factors of each person. With the possibility of contributing to more efficacious treatments, the rise in genomic advancements, increase in disease complexity and regulatory backing, personalized medicine is becoming increasingly important. RNA sequencing methods play a crucial role in identifying and quantifying the expression levels of RNA molecules in a sample, providing a thorough analysis of transcriptomes, and offering insights into gene expression trends, alternative splicing occurrences, and RNA alterations. For example, in February 2024, as reported by the Personalized Medicine Coalition, a non-profit organization based in the US, 16 innovative personalized therapies for patients suffering from unusual diseases were sanctioned by the FDA in 2023, signifying a notable increase from the six that were authorized in 2022. As a result, the rising emphasis on precision medicine is fostering the growth of the ribonucleic acid (RNA) sequencing market.

How Is The Ribonucleic Acid (RNA) Sequencing Market Segmented Across Key Categories?

The ribonucleic acid (rna) sequencingmarket covered in this report is segmented –

1) By Product Type: Instruments; Reagents And Kits; Software

2) By Technology: Single Molecule Based Sequencing; Sequence By Synthesis Technology; Nanopore Sequencing Technology; Ion Torrent Semiconductor Sequencing

3) By Applications: Diagnostics; Drug Discovery; Translational Medicine; Other Applications

4) By End User: Research And Academia; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users

Subsegments:

1) By Instruments: Next-Generation Sequencers; Microarray Instruments; Single-Cell Rna Sequencing Instruments

2) By Reagents And Kits: Rna Extraction Kits; Rna Sequencing Kits; Library Preparation Kits

3) By Software: Data Analysis Software; Data Management Software; Bioinformatics Software

What Current And Upcoming Trends Are Shaping The Ribonucleic Acid (RNA) Sequencing Market?

Leading businesses in the RNA sequencing market are prioritizing RNA next-generation sequencing assay in their operations. This approach aims to enhance patient care by offering data-driven insights and precision-based medicine. Using advanced genomic sequencing technologies, RNA next-generation sequencing assay allows for the complete analysis of a patient’s exome. For instance, Tempus, a precision medicine technology company from the US, launched its unique RNA next-generation sequencing assay called ‘Tempus xR’ in June 2023. This new assay is specifically tailored for solid tumors and enables a comprehensive review of the entire transcriptome. It can identify clinically significant fusions in over 100 targeted genes and modified splicing for MET Exon 14 and EGFRvIII. As a result, Tempus xR is particularly useful for physicians interested in RNA fusions or modified splicing, as well as providers, researchers, and biopharma companies who require detailed RNA sequencing analysis of available samples.

Who Are The Leading Companies Driving The Ribonucleic Acid (RNA) Sequencing Market?

Major companies operating in the ribonucleic acid (RNA) sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Genomics Inc., Natera Inc., Myriad Genetics Inc., BGI Genomics Co Ltd., Takara Bio Inc., Cepheid, NeoGenomics Laboratories Inc., Abcam Limited, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., Standard BioTools Inc., Ambry Genetics Corporation, Biocartis SA, CD Genomics

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report

Which Region Dominates The Ribonucleic Acid (RNA) Sequencing Market Today?

North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15665&type=smp

Browse Through More Reports Similar to the Global Ribonucleic Acid (RNA) Sequencing Market 2025, By The Business Research Company

Induction Furnace Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/induction-furnace-global-market-report

Alternative Fuel Vehicles Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/alternative-fuel-vehicles-global-market-report

Ngs Based Rna Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Ribonucleic Acid (RNA) Sequencing Market Expected To Become By 2029 Compared With Its 2025 Level?

The ribonucleic acid (rna) sequencing market has experienced substantial expansion in recent years. It is forecast to grow from $3.25 billion in 2024 to $3.96 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 21.8%. The historical growth for this market can be attributed to an increasing number of drug development activities, a higher prevalence of genetic disorders and target diseases, the growing adoption of miniaturized portable instruments, wider use of biomarker profiling, rising demand for personalized medicine, and the increasing population of cancer patients.

The ribonucleic acid (rna) sequencing market is anticipated to experience significant expansion in the coming years. This market is projected to reach $8.34 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 20.5%. This expansion during the forecast period is driven by several factors, including an increased need for quick and precise disease diagnosis, the rising integration of real-time polymerase chain reaction, a greater call for swift and localized diagnostic testing, an uptick in infectious disease outbreaks, and the necessity for companion diagnostics. Key trends anticipated within this period encompass disease detection and monitoring, advancements in drug discovery, target validation, identification of biomarkers, innovations in DNA sequencing technologies, improvements in diagnostic testing, the evolution of next-generation sequencing (NGS), the application of microfluidics, the use of lab-on-a-chip platforms, and the development of sophisticated molecular diagnostic solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15665&type=smp

Which Drivers Are Shaping The Ribonucleic Acid (RNA) Sequencing Industry’s Market Share?

The ribonucleic acid (RNA) sequencing market is anticipated to expand, driven by a growing emphasis on precision medicine. This innovative medical strategy, also known as personalized medicine, focuses on treatment and prevention by accounting for individual differences in genetics, environment, and lifestyle. Its potential lies in offering more effective treatments, spurred by genomic progress, the growing complexity of diseases, and favorable regulatory backing. RNA sequencing technologies are employed to identify the sequence and measure the expression levels of RNA molecules in a given sample, enabling a thorough analysis of transcriptomes, revealing gene expression patterns, alternative splicing events, and RNA modifications. For example, in February 2024, data from the Personalized Medicine Coalition, a US-based non-profit organization, indicated that the FDA sanctioned 16 new personalized therapies for rare disease patients in 2023, an increase from six in 2022. Consequently, the heightened attention on precision medicine is a key driver for the ribonucleic acid (RNA) sequencing market.

What Are The Emerging Segments Gaining Attention In The Ribonucleic Acid (RNA) Sequencing Market?

The ribonucleic acid (rna) sequencingmarket covered in this report is segmented –

1) By Product Type: Instruments; Reagents And Kits; Software

2) By Technology: Single Molecule Based Sequencing; Sequence By Synthesis Technology; Nanopore Sequencing Technology; Ion Torrent Semiconductor Sequencing

3) By Applications: Diagnostics; Drug Discovery; Translational Medicine; Other Applications

4) By End User: Research And Academia; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users

Subsegments:

1) By Instruments: Next-Generation Sequencers; Microarray Instruments; Single-Cell Rna Sequencing Instruments

2) By Reagents And Kits: Rna Extraction Kits; Rna Sequencing Kits; Library Preparation Kits

3) By Software: Data Analysis Software; Data Management Software; Bioinformatics Software

How Are Emerging Market Trends Shaping The Ribonucleic Acid (RNA) Sequencing Industry Landscape?

Leading companies operating in the ribonucleic acid (RNA) sequencing market are prioritizing RNA next-generation sequencing assay to enhance patient care through data-driven insights and precision medicine. The RNA next-generation sequencing assay functions as a next-generation exome sequencing platform, leveraging advanced genomic sequencing technologies to analyze a patient’s entire exome. For example, in June 2023, Tempus, a US-based precision medicine technology company, launched its new standalone RNA next-generation sequencing assay, Tempus xR. This innovative assay, developed for solid tumors, delivers a comprehensive analysis of the entire transcriptome, underscoring clinically significant fusions in over 100 targeted genes and altered splicing for MET Exon 14 and EGFRvIII. This specific offering serves physicians with a particular interest in RNA fusions or altered splicing, alongside providers, researchers, and biopharma companies desiring detailed RNA sequencing analysis of their existing samples.

Who Are The Major Companies Operating In The Ribonucleic Acid (RNA) Sequencing Market?

Major companies operating in the ribonucleic acid (RNA) sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Genomics Inc., Natera Inc., Myriad Genetics Inc., BGI Genomics Co Ltd., Takara Bio Inc., Cepheid, NeoGenomics Laboratories Inc., Abcam Limited, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., Standard BioTools Inc., Ambry Genetics Corporation, Biocartis SA, CD Genomics

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report

Which Regional Markets Are Contributing Most To The Ribonucleic Acid (RNA) Sequencing Industry Expansion?

North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Ribonucleic Acid (RNA) Sequencing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15665&type=smp

Browse Through More Reports Similar to the Global Ribonucleic Acid (RNA) Sequencing Market 2025, By The Business Research Company

Induction Furnace Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/induction-furnace-global-market-report

Alternative Fuel Vehicles Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/alternative-fuel-vehicles-global-market-report

Ngs Based Rna Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Ribonucleic Acid (RNA) Sequencing Market Size From 2025 to 2034?

There has been an exponential growth in the size of the ribonucleic acid (rna) sequencing market in the past few years. The market is projected to escalate from a worth of $3.25 billion in 2024 to approximately $3.96 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 21.8%. The notable growth observed in the past can be credited to the upsurge in drug development activities, increased incidence of genetic disorders and targeted diseases, the rising utilization of compact portable devices, the growing application of biomarker profiling, rising demand for personalized medicine, and the mounting number of cancer cases.

Anticipated to experience significant expansion in the coming years, the ribonucleic acid (rna) sequencing market size is projected to reach$8.34 billion by 2029, with a compound annual growth rate (CAGR) of 20.5%. The growth trajectory during the forecast period could be attributed to several factors such as the burgeoning demand for swift and precise disease diagnosis, increasing usage of real-time polymerase chain reaction, the escalating need for quick and on-site diagnostic testing, an upsurge in infectious disease incidents, and a growing demand for companion diagnostics. In the forecasted period, significant market trends would involve disease detection and monitoring, drug discovery, target validation, the identification of biomarkers, advancements in DNA sequencing technologies, enhancement in diagnostic testing approaches, the emergence of next-generation sequencing (NGS), microfluidics, the advent of lab-on-a-chip platforms, and progress in advanced molecular diagnostic solutions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15665&type=smp

What are the Fundamental Drivers and Innovations Shaping the Ribonucleic Acid (RNA) Sequencing Market?

The projected growth of the ribonucleic acid (RNA) sequencing market is owed to an intensified concentration on precision medicine. This cutting-edge medical treatment and prevention method factors in the individual divergences in genes, environment, and lifestyle for each individual. By offering superiorly effective treatments, advancing genomics, escalating disease complexity, and enjoying regulatory endorsement, personalized medicine holds much promise. RNA sequencing technologies, used for determining sequence and gauging the expression levels of RNA molecules within a sample, allow for in-depth scrutiny of transcriptomes, shedding light on gene expression patterns, alternative splicing events, and RNA modifications. For example, the Personalized Medicine Coalition, a non-profit group based in the US, reported in February 2024 that the FDA had given the thumbs-up to 16 new personalized therapies for patients with rare diseases in 2023, a steep increase from six in 2022. As such, the rising emphasis on precision medicine is propelling the ribonucleic acid (RNA) sequencing market forward.

How Is the Ribonucleic Acid (RNA) Sequencing Market Segmented?

The ribonucleic acid (rna) sequencingmarket covered in this report is segmented –

1) By Product Type: Instruments; Reagents And Kits; Software

2) By Technology: Single Molecule Based Sequencing; Sequence By Synthesis Technology; Nanopore Sequencing Technology; Ion Torrent Semiconductor Sequencing

3) By Applications: Diagnostics; Drug Discovery; Translational Medicine; Other Applications

4) By End User: Research And Academia; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users

Subsegments:

1) By Instruments: Next-Generation Sequencers; Microarray Instruments; Single-Cell Rna Sequencing Instruments

2) By Reagents And Kits: Rna Extraction Kits; Rna Sequencing Kits; Library Preparation Kits

3) By Software: Data Analysis Software; Data Management Software; Bioinformatics Software

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15665&type=smp

Which Regions Are Driving the Next Phase of the Ribonucleic Acid (RNA) Sequencing Market Growth?

North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Ribonucleic Acid (RNA) Sequencing Market?

Significant businesses in the ribonucleic acid (RNA) sequencing industry are concentrating their efforts on RNA next-generation sequencing assays to enhance patient treatment through intelligent data analysis and precision medicine. The RNA next-generation sequencing assay, a cutting-edge exome sequencing system, utilizes revolutionary genomic sequencing techniques to examine a patient’s entire exome. For example, in June 2023, the American precision medicine technology firm Tempus introduced Tempus xR, a fresh standalone RNA next-generation sequencing assay. Tailored for solid tumors, this groundbreaking assay undertakes a comprehensive review of the full transcriptome, marking clinically relevant fusions in over 100 targeted genes and altered splicing for MET Exon 14 and EGFRvIII. Tempus xR appeals to medical professionals particularly interested in RNA fusions or altered splicing, and to providers, investigators, and biopharmaceutical firms requiring detailed RNA sequencing examination of their available samples.

View the full report here:

https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report

How Is the Ribonucleic Acid (RNA) Sequencing Market Defined and What Are Its Core Parameters?

Ribonucleic acid (RNA) sequencing refers to a technique that uses next-generation sequencing to reveal the presence and quantity of RNA molecules in a biological sample, providing a snapshot of gene expression in the sample. It enables researchers to study gene expression, identify novel transcripts, and understand RNA processing.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15665

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of theRibonucleic Acid (RNA) Sequencing Market?

An increasing focus on precision medicine is driving the growth of the ribonucleic acid (RNA) sequencing market, supported by advancements in genomics and personalized treatment strategies. For example, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 personalized therapies for rare diseases in 2023, up from six in 2022.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15665&type=smp

#What Growth Opportunities Will Drive the Ribonucleic Acid (RNA) Sequencing Market’s CAGR Through 2034?

The ribonucleic acid (RNA) sequencing market has expanded exponentially in recent years. It will grow from $3.25 billion in 2024 to $3.98 billion in 2025, with a compound annual growth rate (CAGR) of 22.7%. The growth is attributed to an increase in drug development activities, a rise in genetic disorders and target diseases, the use of miniaturized portable instruments, biomarker profiling, personalized medicine, and a growing number of cancer patients.

The ribonucleic acid (RNA) sequencing market is expected to grow to $8.91 billion by 2029, at a CAGR of 22.3%. This growth is attributed to the rising demand for rapid and accurate disease diagnosis, real-time polymerase chain reaction adoption, infectious disease outbreaks, and companion diagnostics. Trends include disease detection, drug discovery, NGS advancements, and lab-on-a-chip platforms.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15665

Which Cutting-Edge Market Trends Are Expected to Drive theRibonucleic Acid (RNA) Sequencing Market’s Growth?

Major companies in the ribonucleic acid (RNA) sequencing market are focusing on RNA next-generation sequencing assays to advance patient care. In June 2023, Tempus, a precision medicine technology company from the U.S., launched the Tempus xR RNA next-generation sequencing assay. This assay offers a comprehensive analysis of solid tumors, focusing on clinically significant fusions and altered splicing, helping physicians make informed treatment decisions.

What Are the Leading Market Players Impacting theRibonucleic Acid (RNA) Sequencing Market’s Growth Trend?

Major companies operating in the ribonucleic acid (RNA) sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Genomics Inc., Natera Inc., Myriad Genetics Inc., BGI Genomics Co Ltd., Takara Bio Inc., Cepheid, NeoGenomics Laboratories Inc., Abcam Limited, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., Standard BioTools Inc., Ambry Genetics Corporation, Biocartis SA, CD Genomics

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report

How Are the Key Segments of the Ribonucleic Acid (RNA) Sequencing Market Driving Opportunities and Innovations?

The ribonucleic acid (RNA) sequencing market covered in this report is segmented –

1) By Product Type: Instruments, Reagents And Kits, Software

2) By Technology: Single Molecule Based Sequencing, Sequence By Synthesis Technology, Nanopore Sequencing Technology, Ion Torrent Semiconductor Sequencing

3) By Applications: Diagnostics, Drug Discovery, Translational Medicine, Other Applications

4) By End User: Research And Academia, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Instruments: Next-Generation Sequencers, Microarray Instruments, Single-Cell Rna Sequencing Instruments

2) By Reagents And Kits: Rna Extraction Kits, Rna Sequencing Kits, Library Preparation Kits

3) By Software: Data Analysis Software, Data Management Software, Bioinformatics Software

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15665&type=smp

What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theRibonucleic Acid (RNA) Sequencing Market?# Market Expansion?

North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Ribonucleic Acid (RNA) Sequencing Market 2025, By The Business Research Company:

Returnable Packaging Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/returnable-packaging-global-market-report

External Cloud Automotive Cyber Security Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/external-cloud-automotive-cyber-security-services-global-market-report

NGS-Based RNA-Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the ribonucleic acid (rna) sequencing market grown in recent years?

The market size for ribonucleic acid (RNA) sequencing has experienced rapid growth in the recent past. The market is forecasted to increase from $3.25 billion in 2024 to $3.98 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 22.7%. Factors such as an upturn in drug development initiatives, a surge in genetic disorders and targeted diseases, wider adoption of compact portable devices, increased use of biomarker profiling, and a rise in demand for personalized medication, coupled with an increasing cancer patient population, have contributed to the growth observed in the historic period.

How is the ribonucleic acid (rna) sequencing market size expected to evolve during the forecast period?

The ribonucleic acid (RNA) sequencing market size is expected to see exponential growth in the next few years. It will grow to $8.91 billion in 2029 at a compound annual growth rate (CAGR) of 22.3%. The growth in the forecast period can be attributed to rise in demand for rapid and accurate diagnosis of disease, growing adoption of real-time polymerase chain reaction, the growing demand for rapid and on-site diagnostic testing, rise in infectious disease outbreaks, and demand for companion diagnostics. Major trends in the forecast period include disease detection and monitoring, drug discovery, target validation, biomarker identification, DNA sequencing technologies, diagnostic testing advancements, next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and advanced molecular diagnostic solutions development.

Get your ribonucleic acid (rna) sequencing market report here!

https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report

Which key drivers are propelling the ribonucleic acid (rna) sequencing market’s growth?

The ribonucleic acid (RNA) sequencing market is anticipated to expand due to a heightened emphasis on precision medicine. This cutting-edge medical approach, also referred to as personalized medicine, takes into account individual variations in genes, environmental factors, and lifestyle habits. It holds the promise of yielding more effective treatments, driving genomics advancements, coping with increasing disease complexity, and garnerning regulatory support. RNA sequencing technology plays a fundamental role in determining the sequence and quantifying the expression levels of RNA molecules within a sample. This technology facilitates a detailed analysis of transcriptomes, producing insights into gene expression patterns, alternative splicing events, and RNA alterations. For example, in February 2024, the Personalized Medicine Coalition, a U.S. non-profit organization, reported that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, a significant increase from the six approvals in 2022. Consequently, the escalating emphasis on precision medicine is fueling the growth of the RNA sequencing market.

What are the market segments in the ribonucleic acid (rna) sequencing industry?

The ribonucleic acid (RNA) sequencing market covered in this report is segmented –

1) By Product Type: Instruments, Reagents And Kits, Software

2) By Technology: Single Molecule Based Sequencing, Sequence By Synthesis Technology, Nanopore Sequencing Technology, Ion Torrent Semiconductor Sequencing

3) By Applications: Diagnostics, Drug Discovery, Translational Medicine, Other Applications

4) By End User: Research And Academia, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Instruments: Next-Generation Sequencers, Microarray Instruments, Single-Cell Rna Sequencing Instruments

2) By Reagents And Kits: Rna Extraction Kits, Rna Sequencing Kits, Library Preparation Kits

3) By Software: Data Analysis Software, Data Management Software, Bioinformatics Software

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15665&type=smp

What are the top market players propelling the growth of the ribonucleic acid (rna) sequencing industry?

Major companies operating in the ribonucleic acid (RNA) sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Genomics Inc., Natera Inc., Myriad Genetics Inc., BGI Genomics Co Ltd., Takara Bio Inc., Cepheid, NeoGenomics Laboratories Inc., Abcam Limited, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., Standard BioTools Inc., Ambry Genetics Corporation, Biocartis SA, CD Genomics

What key trends are currently impacting the ribonucleic acid (rna) sequencing market’s development?

Top firms in the RNA sequencing market are emphasizing on RNA next-generation sequencing assay to enhance patient care by utilizing data-driven intelligence and precision medicine. The RNA next-generation sequencing assay is a cutting-edge exome sequencing platform that employs top-tier genomic sequencing techniques to investigate a patient’s complete exome. For example, in June 2023, Tempus, a precision medicine technology enterprise based in the US, launched its standalone RNA next-generation sequencing assay, Tempus xR. This groundbreaking assay, tailored for solid tumors, provides comprehensive exploration of the total transcriptome, illuminating clinically crucial fusions in upwards of 100 targeted genes and altered splicing for MET Exon 14 and EGFRvIII. This product meets the needs of physicians who have a keen interest in RNA fusions or altered splicing, and it additionally serves providers, researchers, and biopharma companies in search of intensive RNA sequencing analysis of their current samples.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15665

Which geographic areas are influencing the growth of the ribonucleic acid (rna) sequencing market?

North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Returnable Packaging Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/returnable-packaging-global-market-report

External Cloud Automotive Cyber Security Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/external-cloud-automotive-cyber-security-services-global-market-report

NGS-Based RNA-Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Anticipated CAGR of the Ribonucleic Acid (RNA) Sequencing Market, and What Factors Will Drive It?

The market size for ribonucleic acid (RNA) sequencing has seen an exponential increase in the recent past. It is projected to expand from $3.25 billion in 2024 to $3.98 billion in 2025, with a compound annual growth rate (CAGR) of 22.7%. The significant growth during the historic period is linked to the surge in drug development activities, increased incidence of genetic disorders and target diseases, rising adoption of compact portable instruments, escalating application of biomarker profiling, growing preference for personalized medicine, and an increase in cancer patient numbers.

The market size for RNA (ribonucleic acid) sequencing is anticipated to experience a massive growth in the upcoming years, reaching $8.91 billion in 2029 with a compound annual growth rate (CAGR) of 22.3%. Factors contributing to this predicted growth during the forecast period includes an elevated demand for reliable and quick disease diagnosis, a rise in the utilization of real-time polymerase chain reaction, an increase in the requirement for swift and on-the-spot diagnostic testing, an upsurge in infectious disease epidemics, and an increased requirement for companion diagnostics. The main trends anticipated in the forecast period encompass disease discovery and tracking, drug development, target verification, biomarker discovery, DNA sequencing technologies, advancements in diagnostic testing, next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and the advancement of sophisticated molecular diagnostic solutions.

How Are the key drivers expanding the growth of the Ribonucleic Acid (RNA) Sequencing Market?

The upward trajectory of the ribonucleic acid (RNA) sequencing market is projected to continue, fueled by an intensified interest in precision medicine. This medical paradigm – also known as personalized medicine – is a revolutionary approach to treatment and prevention that takes into account individual differences in genetics, environmental factors and lifestyle habits. Personalized medicine shows potential for enhancing the effectiveness of treatments through leveraging advancements in genomics, addressing increasing disease complexity, and obtaining regulatory backing. RNA sequencing methodologies are of paramount importance to ascertain both the sequencing and quantification of RNA molecule expression levels in a sample. This comprehensive transcriptome analysis allows for deeper understanding of gene expression patterns, alternate splicing events, and modifications to RNA. Illustrating this point, the Personalized Medicine Coalition, a non-profit organization based in the US, reported in February 2024 that the FDA had granted approval to 16 new personalized treatments for rare disease patients in 2023, while only six such treatments had been approved the previous year. Consequently, the growing emphasis on precision medicine is bolstering the growth of the ribonucleic acid (RNA) sequencing market.

Request Your Free Ribonucleic Acid (RNA) Sequencing Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=15665&type=smp

Who Are the Top Companies Contributing to the Growth of the Ribonucleic Acid (RNA) Sequencing Market?

Major companies operating in the ribonucleic acid (RNA) sequencing market are:

• F. Hoffmann-La Roche Ltd.

• Thermo Fisher Scientific Inc.

• Danaher Corporation

• Merck KGaA

• Becton

How Are Technological Trends Affecting the Growth and Development of the Ribonucleic Acid (RNA) Sequencing Market?

In the ribonucleic acid (RNA) sequencing market, leading firms are focusing their efforts on RNA next-generation sequencing assays. Their primary objective is to enhance patient care using precise data insights and precision medicine. These assays represent a new era of exome sequencing platforms that utilize sophisticated genomic sequencing technologies to examine a patient’s entire exome. For instance, in June 2023, Tempus, an American firm specializing in precision medicine technologies, launched its unique standalone RNA next-generation sequencing assay, Tempus xR. This groundbreaking assay is designed specifically for solid tumors and provides a comprehensive overview of the entire transcriptome. Notably, it discerns clinically significant fusions in more than 100 targeted genes and identifies altered splicing for MET Exon 14 and EGFRvIII. The Tempus xR assay is particularly beneficial for physicians interested in RNA fusions or altered splicing, and for providers, researchers, and biopharma companies in need of in-depth RNA sequencing analysis for their samples.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report

What Are the Major Categories and Their Growth Dynamics in the Ribonucleic Acid (RNA) Sequencing Market?

The ribonucleic acid (RNA) sequencing market covered in this report is segmented –

1) By Product Type: Instruments, Reagents And Kits, Software

2) By Technology: Single Molecule Based Sequencing, Sequence By Synthesis Technology, Nanopore Sequencing Technology, Ion Torrent Semiconductor Sequencing

3) By Applications: Diagnostics, Drug Discovery, Translational Medicine, Other Applications

4) By End User: Research And Academia, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Instruments: Next-Generation Sequencers, Microarray Instruments, Single-Cell Rna Sequencing Instruments

2) By Reagents And Kits: Rna Extraction Kits, Rna Sequencing Kits, Library Preparation Kits

3) By Software: Data Analysis Software, Data Management Software, Bioinformatics Software

What Are the Key Regions Powering Growth in the Ribonucleic Acid (RNA) Sequencing Market?

North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Defines the Scope of the Ribonucleic Acid (RNA) Sequencing Market?

Ribonucleic acid (RNA) sequencing refers to a technique that uses next-generation sequencing to reveal the presence and quantity of RNA molecules in a biological sample, providing a snapshot of gene expression in the sample. It enables researchers to study gene expression, identify novel transcripts, and understand RNA processing.

Browse Through More Similar Reports By The Business Research Company:

Returnable Packaging Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/returnable-packaging-global-market-report

External Cloud Automotive Cyber Security Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/external-cloud-automotive-cyber-security-services-global-market-report

NGS-Based RNA-Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: